Xavier Filella Selected Research

antigen CYFRA21.1

10/2011	Increased plasma concentrations of tumour markers in the absence of neoplasia.
1/2009	Usefulness of serum tumor markers, including progastrin-releasing peptide, in patients with lung cancer: correlation with histology.
1/2008	Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as tumor markers in patients with lung cancer: comparison with CYFRA 21-1, CEA, SCC and NSE.
5/2005	Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer.
5/2005	CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA.
1/2005	Low utility of CYFRA 21-1 serum levels for diagnosis and follow-up in bladder cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xavier Filella Research Topics

Disease

23	Neoplasms (Cancer) 01/2020 - 05/2003
17	Prostatic Neoplasms (Prostate Cancer) 02/2020 - 06/2004
7	Lung Neoplasms (Lung Cancer) 02/2016 - 01/2004
7	Multiple Myeloma 01/2014 - 05/2004
6	Infections 05/2021 - 08/2002
5	Adenocarcinoma 06/2012 - 05/2005
5	Renal Insufficiency (Renal Failure) 04/2012 - 01/2004
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2016 - 05/2003
4	Pathologic Complete Response 01/2014 - 12/2009
4	Disease Progression 07/2013 - 01/2003
4	Breast Neoplasms (Breast Cancer) 01/2012 - 01/2003
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2009 - 01/2004
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2009 - 01/2004
3	Premature Obstetric Labor (Premature Labor) 01/2021 - 05/2009
3	Necrosis 01/2020 - 03/2008
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2017 - 01/2004
3	Liver Diseases (Liver Disease) 04/2012 - 01/2008
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2005 - 11/2002
2	Sepsis (Septicemia) 05/2021 - 03/2008
2	Inflammation (Inflammations) 01/2021 - 10/2010
2	Colorectal Neoplasms (Colorectal Cancer) 09/2014 - 12/2013
2	Jaundice (Icterus) 06/2012 - 04/2012
2	Pneumonia (Pneumonitis) 01/2012 - 04/2004
2	Myocardial Infarction 12/2008 - 11/2002
2	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 03/2008 - 01/2007
2	Carcinoma (Carcinomatosis) 05/2005 - 05/2003
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2005 - 05/2003
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2005 - 06/2004
2	Fever (Fevers) 08/2004 - 02/2002
2	Plasmacytoma 07/2004 - 05/2004
1	Infertility (Sterility) 05/2021
1	Cardiogenic Shock 02/2020
1	Encephalitis (Encephalitis, Rasmussen) 01/2020
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2020
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2020
1	Osteoporosis 01/2020
1	Fibrosis (Cirrhosis) 01/2019
1	Hepatorenal Syndrome 01/2019
1	Secondary Hyperparathyroidism 01/2019
1	Hypocalcemia 01/2019
1	Acute Kidney Injury (Acute Renal Failure) 01/2019
1	Osteitis Deformans (Paget's Disease of Bone) 01/2019
1	Circulating Neoplastic Cells 01/2018
1	Thyroid Neoplasms (Thyroid Cancer) 03/2017
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2017

Drug/Important Bio-Agent (IBA)

18	Tumor Biomarkers (Tumor Markers)IBA 02/2020 - 01/2002
17	Interleukin-6 (Interleukin 6)IBA 01/2021 - 02/2002
15	Biomarkers (Surrogate Marker)IBA 10/2019 - 08/2003
10	Prostate-Specific Antigen (Semenogelase)IBA 02/2020 - 06/2004
7	CytokinesIBA 01/2020 - 08/2002
6	Carcinoembryonic AntigenIBA 02/2016 - 05/2003
6	antigen CYFRA21.1IBA 10/2011 - 01/2005
5	pro-gastrin-releasing peptide (31-98)IBA 03/2017 - 01/2004
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 02/2002
5	AntigensIBA 02/2016 - 01/2007
5	Peptides (Polypeptides)IBA 02/2016 - 07/2004
5	big gastrinIBA 02/2016 - 07/2004
5	Proteins (Proteins, Gene)FDA Link 07/2013 - 01/2004
4	MicroRNAs (MicroRNA)IBA 10/2019 - 05/2017
3	InterleukinsIBA 01/2020 - 11/2002
3	Phosphopyruvate Hydratase (Enolase)IBA 02/2016 - 10/2011
3	CarbohydratesIBA 02/2016 - 07/2010
3	Keratin-19 (Keratin 19)IBA 02/2016 - 01/2005
3	Hemoglobins (Hemoglobin)IBA 09/2014 - 02/2002
3	Anti-Bacterial Agents (Antibiotics)IBA 08/2004 - 01/2004
2	Interleukin-10 (Interleukin 10)IBA 01/2020 - 11/2002
2	C-Reactive ProteinIBA 01/2020 - 03/2008
2	GlucocorticoidsIBA 01/2020 - 02/2003
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 02/2002
2	Kallikreins (Kallikrein)IBA 01/2018 - 06/2015
2	NF-kappa B (NF-kB)IBA 04/2013 - 09/2006
2	Docetaxel (Taxotere)FDA Link 04/2013 - 09/2006
2	Immunoglobulins (Immunoglobulin)IBA 07/2012 - 01/2011
2	Oncogene Proteins (Oncogene Protein)IBA 01/2012 - 06/2010
2	Oligoclonal BandsIBA 01/2011 - 12/2009
2	Estrogen ReceptorsIBA 07/2010 - 06/2010
2	Thalidomide (Thalomid)FDA Link 07/2004 - 05/2004
2	CreatinineIBA 01/2004 - 01/2004
2	Interleukin-8 (Interleukin 8)IBA 01/2004 - 11/2002
1	SolutionsIBA 05/2021
1	Rituximab (Mabthera)FDA Link 01/2020
1	etelcalcetide hydrochlorideIBA 01/2019
1	PeriostinIBA 01/2019
1	Tartrate-Resistant Acid PhosphataseIBA 01/2019
1	Lipocalin-2IBA 01/2019
1	Cinacalcet (Sensipar)FDA Link 01/2019
1	CalciumIBA 01/2019
1	Androgen Receptors (Androgen Receptor)IBA 01/2018
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 03/2017
1	Tyrosine Kinase InhibitorsIBA 03/2017
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2017
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2014

Therapy/Procedure

6	Therapeutics 01/2011 - 02/2002
4	Stem Cell Transplantation 01/2014 - 08/2004
2	Renal Dialysis (Hemodialysis) 01/2019 - 01/2004
2	Transplantation 07/2013 - 07/2012
2	Hematopoietic Stem Cell Transplantation 07/2012 - 12/2009
1	Catheters 05/2021
1	Length of Stay 02/2020
1	Intravenous Administration 01/2019